Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Summit Therapeutics (SMMT) has a market cap of $18.16 billion USD. According to our data, Summit Therapeutics is ranked No.995 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $18.16 B |
38.01%
|
| Dec 31, 2024 | $13.16 B |
583.72%
|
| Dec 29, 2023 | $1.92 B |
-38.59%
|
| Dec 30, 2022 | $3.13 B |
57.99%
|
| Dec 31, 2021 | $1.98 B |
-42.77%
|
| Dec 31, 2020 | $3.47 B |
193.75%
|
| Dec 31, 2019 | $1.18 B |
39.13%
|
| Dec 31, 2018 | $0.85 B |
-89.62%
|
| Dec 29, 2017 | $8.17 B |
29.44%
|
| Dec 30, 2016 | $6.31 B |
-25.57%
|
| Dec 31, 2015 | $8.48 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
| Market Cap | = | SMMT Stock Price | * | SMMT Shares Outstanding |
| = | $24.62 | * | 0.74 B | |
| = | $18.16 B |